Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
1,275.00
-1.60 (-0.13%)
Aug 22, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Global Generics | 289.55B | Log In | Log In | Log In | Log In | Upgrade |
Global Generics Growth | 17.97% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Services and Active Ingredients | 33.85B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Services and Active Ingredients Growth | 13.57% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.14B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -45.35% | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Products | - | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Products Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.14B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -45.35% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Other | 94.40B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 29.62% | Log In | Log In | Log In | Log In | Upgrade |
United States | 149.35B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 10.17% | Log In | Log In | Log In | Log In | Upgrade |
India | 55.83B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | 15.18% | Log In | Log In | Log In | Log In | Upgrade |
Russia | 25.96B | Log In | Log In | Log In | Log In | Upgrade |
Russia Growth | 16.40% | Log In | Log In | Log In | Log In | Upgrade |
Other | 94.40B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 29.62% | Log In | Log In | Log In | Log In | Upgrade |